Clinical Trials

Susan G. Komen is excited to announce the launch of a new clinical trial education campaign that will empower people with trustworthy, accurate, current, and evidence-based information to dispel myths and increase awareness of breast cancer clinical trials.

Breast cancer treatment and care has made tremendous progress over the past 40 years, thanks in large part to the information gained through clinical trials. In fact, clinical trials are a key part of all advances against breast cancer. However, navigating cancer patients through the complexities of the clinical research field continues to be a challenge.

A 2018 report from the Cancer Action Network indicated clinical trial enrollment by U.S. cancer patients averages only 8% (14.8% at academic centers and 6.3% at community centers). And, 1 in 5 cancer clinical trials fail due to insufficient patient enrollment. These failed trials represent countless missed opportunities for potential breakthroughs in improving patient care.

We believe it is vitally important to increase the number of breast cancer clinical trial participants because THIS is how new therapeutics will be developed – and eventually delivered to the communities we serve – and, ULTIMATELY, will help us achieve our Bold Goal to reduce the current number of breast cancer deaths by 50% in the U.S. by 2026.

New Online Resource:

The online home for Komen’s clinical trial education campaign is a new webpage – – that features:

  • information about the importance of clinical trials,
  • highlighted clinical trials,
  • videos and interactive resources,
  • links to Komen resources like the Clinical Trial Information Helpline, and
  • links to breast cancer clinical trial search tools.